References
- Awad S, Ryan D, Prochasson P, et al. The Snf2 homolog Fun30 acts as a homodimeric ATP-dependent chromatin-remodeling enzyme. J Biol Chem. 2010;285(13):9477–9484.
- Chen X, Cui D, Papusha A, et al. The Fun30 nucleosome remodeller promotes resection of DNA double-strand break ends. Nature. 2012 Sep;489(7417):576–580.
- Costelloe T, Louge R, Tomimatsu N, et al. The yeast Fun30 and human SMARCAD1 chromatin remodellers promote DNA end resection. Nature. 2012 Sep;489(7417):581–584.
- Eapen VV, Sugawara N, Tsabar M, et al. The Saccharomyces cerevisiae chromatin remodeler Fun30 regulates DNA end resection and checkpoint deactivation. Mol Cell Biol. 2012;32(22):4727–4740.
- Neves-Costa A, Will WR, Vetter AT, et al. The SNF2-family member Fun30 promotes gene silencing in heterochromatic loci. PLoS One. 2009;4(12):e8111.
- Yu Q, Zhang X, Bi X. Roles of chromatin remodeling factors in the formation and maintenance of heterochromatin structure. J Biol Chem. 2011;286(16):14659–14669.
- Byeon B, Wang W, Barski A, et al. The ATP-dependent chromatin remodeling enzyme Fun30 represses transcription by sliding promoter-proximal nucleosomes. J Biol Chem. 2013;288(32):23182–23193.
- Ubersax JA, Woodbury EL, Quang PN, et al. Targets of the cyclin-dependent kinase Cdk1. Nature. 2003;425(6960):859–864.
- Soininen R, Schoor M, Henseling U, et al. The mouse Enhancer trap locus 1 (Etl-1): a novel mammalian gene related to Drosophila and yeast transcriptional regulator genes. Mech Dev. 1992;39(1–2):111–123.
- Schoor M, Schuster-Gossler K, Gossler A. The Etl-1 gene encodes a nuclear protein differentially expressed during early mouse development. Dev Dyn. 1993;197(3):227–237.
- Mermoud JE, Rowbotham SP, Varga-Weisz PD. Keeping chromatin quiet: how nucleosome remodeling restores heterochromatin after replication. Cell Cycle. 2011;10(23):4017–4025.
- Shin EM, Hay HS, Lee MH, et al. DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest. 2014;124(9):3807–3824.
- Bai J, Mei P, Zhang C, et al. BRG1 is a prognostic marker and potential therapeutic target in human breast cancer. PLoS One. 2013;8(3):e59772.
- Attoub S, Arafat K, Hammadi NK, et al. Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formation. Sci Rep. 2015;5:12759.
- Zen K, Liu DQ, Guo YL, et al. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLoS One. 2008;3(3):e1826.
- El Hasasna H, Saleh A, Samri HA, et al. Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFκB and nitric oxide pathways. Sci Rep. 2016;6:21144.
- Limame R, de Beeck KO, Van Laere S, et al. Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer. Oncoscience. 2014;1(1):69–81.
- Seki Y, Toba K, Fuse I, et al. In vitro effect of cyclosporin A, mitomycin C and prednisolone on cell kinetics in cultured human umbilical vein endothelial cells. Thromb Res. 2005;115(3):219–228.
- Rivat C, Christine R, Rodrigues S, et al. Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) – and vascular endothelial growth factor-mediated cellular invasion and tumor growth. Cancer Res. 2005;65(1):195–202.
- Kamran MZ, Patil P, Gude RP. Role of STAT3 in cancer metastasis and translational advances. Biomed Res Int. 2013;2013:421821.
- Chen HH, Yu HI, Cho WC, et al. DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway. Oncogene. 2015;34(21):2790–2800.
- Li XL, Lu X, Parvathaneni S, et al. Identification of RECQ1-regulated transcriptome uncovers a role of RECQ1 in regulation of cancer cell migration and invasion. Cell Cycle. 2014;13(15):2431–2445.
- Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis. Oncogene. 2000;19(21):2474–2488.
- Marotta LL, Almendro V, Marusyk A, et al. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. J Clin Invest. 2011;121(7):2723–2735.
- An H, Kim JY, Oh E, et al. Salinomycin promotes anoikis and decreases the CD44+/CD24- stem-like population via inhibition of STAT3 activation in MDA-MB-231 cells. PLoS One. 2015;10(11):e0141919.
- Diaz N, Minton S, Cox C, et al. Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Clin Cancer Res. 2006;12(1):20–28.